AbbVie launches lab space award program for Quebec biotechs
AbbVie is opening submissions for an award that will provide one Canadian biotech with free access to lab space and executive insights from the Big Pharma. The most recent iteration…
AbbVie halts development of Dragonfly cancer asset midflight
AbbVie has scrapped an asset from its ongoing collaboration with Dragonfly Therapeutics, a spokesperson for the Chicago pharma confirmed to Fierce Biotech. “We have terminated clinical activity around ABBV-303,” the…
AbbVie, Regeneron and Sanofi help fund $80M series A round for Tregs specialist Zag Bio
With a new approach to creating thymus-targeted medicines for autoimmune diseases, Zag Bio has emerged from stealth with the help of backing from pharma giants AbbVie, Regeneron and Sanofi. The…